Market Research Logo

Global Herpes Treatment Market 2017-2021

Global Herpes Treatment Market 2017-2021

About Herpes Treatment

Herpesviruses belong to double-stranded DNA viruses, which are responsible for a large number of diseases in humans and animals. There are eight types of human herpesvirus (HHV) that affects humans. Among these, herpes simplex virus (HSV) and varicella-zoster virus (VZV) are the two most commonly found HHVs that causes severe infections in humans. HSV is further segmented into oral herpes and genital herpes.

Technavio’s analysts forecast the global herpes treatment market to grow at a CAGR of 12.97% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global herpes treatment market for 2017-2021. To calculate the market size, the report considers the sales of both branded and generic drugs in herpes treatment market.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Herpes Treatment Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Gilead
  • GlaxoSmithKline
  • Merck
  • Novartis
Other prominent vendors
  • Abbott
  • Agenus
  • Genocea
  • Mylan
  • Teva Pharmaceutical Industries
  • Vical
Market driver
  • Increasing prevalence of herpes infection
  • For a full, detailed list, view our report
Market challenge
  • Side effects of drugs
  • For a full, detailed list, view our report
Market trend
  • Emergence of novel therapies
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Herpes Treatment Market 2017-2021

Technavio recognizes the following companies as the key players in the global herpes treatment market: Gilead, GlaxoSmithKline, Merck, and Novartis.

Other Prominent Vendors in the market are: Abbott, Agenus, Genocea, Mylan, Teva Pharmaceutical Industries, and Vical.

Commenting on the report, an analyst from Technavio’s team said: “The latest trend gaining momentum in the market is emergence of novel therapies. High dependency on a limited number of therapies is a major challenge being faced by the herpes treatment market. For instance, genital and oral herpes at present do not have any cure; the disease can only be managed by the available treatment options. Several studies are under trial and emergence of better therapies are expected in the coming times. The major drugs present for the treatment of genital herpes control the outbreaks of the disease but not the shedding.”

According to the report, one of the major drivers for this market is increasing prevalence of herpes infection. Apart from traditional risk factors such as sexual or physical contact with the infected person, there have been several other factors contributing to the rising prevalence of herpes. People with the weaker immune system due to the intake of immunosuppressants for an organ transplant are vulnerable to herpes infection and is one of the major factors for increasing prevalence of herpes. The immunocompromised status is assumed to be more vulnerable to catch this viral infection.

Further, the report states that one of the major factors hindering the growth of this market is Side effects of drugs. Lack of complete remission of herpes infection is a huge concern as most of the drugs taken by the herpes-infected patients are for symptomatic relief. This combined with the side effects associated with the usage of the drug lead to less patient adherence, thereby, posing as a growth hurdle. To further aid to this, suppressive therapy is suggested by the doctors, if a person sees frequent outbreaks of the infection.



Companies Mentioned

Gilead, GlaxoSmithKline, Merck, Novartis, Abbott, Agenus, Genocea, Mylan, Teva Pharmaceutical Industries, and Vical.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Market outline
    • Disease overview
      • Table Types of HHV
      • Table Symptoms of herpesvirus infection
      • Table Diagnosis and treatment of herpes
  • Market introduction
    • Market overview
      • Table Global herpes treatment market snapshot
    • Market size and forecast
      • Table Global herpes treatment market 2016-2021 ($ millions)
      • Table Opportunity analysis: Global herpes treatment market
    • Five forces analysis
      • Table Five forces analysis
  • Pipeline landscape
    • Table Key pipeline molecules by vendors
    • Table Key clinical trials
  • Market segmentation by virus type
    • Table Global herpes treatment market by virus type
    • Herpes simplex
      • Table Global HSV treatment market
      • Table Market overview: Global HSV treatment market
      • Table Global oral herpes treatment market 2016-2021 ($ millions)
      • Table Global share of HSV-2 infection
      • Table Global genital herpes treatment market 2016-2021 ($ millions)
    • Herpes zoster
      • Table Global herpes zoster treatment market 2016-2021 ($ millions)
  • Geographical segmentation
    • Table Segmentation of global herpes treatment market by geography 2016 and 2021
    • Table Global herpes treatment market revenue by geography 2016-2021 ($ millions)
    • Herpes treatment market in Americas
      • Table Market scenario in Americas
      • Table Herpes treatment market in Americas 2016-2021 ($ millions)
    • Herpes treatment market in EMEA
      • Table Market scenario in EMEA
      • Table Herpes treatment market in EMEA 2016-2021 ($ millions)
    • Herpes treatment market in APAC
      • Table Market scenario of APAC
      • Table Herpes treatment market in APAC 2016-2021 ($ millions)
  • Decision Framework
  • Drivers and challenges
    • Market drivers
      • Table Population at a higher risk of herpes
      • Table Percentage distribution of organ transplants in US 1988-2016
    • Market challenges
  • Market trends
    • Emergence of novel therapies
    • Increasing focus on vaccine development
    • Increasing focus on drug development for preadolescent patients
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure analysis of global herpes treatment market 2016
      • Table Strategic success factors of companies in global herpes treatment market
  • Key vendor analysis
    • Gilead
      • Table Gilead: Key highlights
      • Table Gilead: Strength assessment
      • Table Gilead: Strategy assessment
      • Table Gilead: Opportunity assessment
    • GlaxoSmithKline
      • Table GlaxoSmithKline: Key highlights
      • Table GlaxoSmithKline: Strength assessment
      • Table GlaxoSmithKline: Strategy assessment
      • Table GlaxoSmithKline: Opportunity assessment
    • Merck
      • Table Merck: Key highlights
      • Table Merck: Strength assessment
      • Table Merck: Strategy assessment
      • Table Merck: Opportunity assessment
    • Novartis
      • Table Novartis: Key highlights
      • Table Novartis: Strength assessment
      • Table Novartis: Strategy assessment
      • Table Novartis: Opportunity assessment
    • Other prominent vendors
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report